Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
Referrals to patient-related programs or resources
Donations, website, or event-related assistance
Tobacco-related topics
Volunteer opportunities
Cancer Information
For medical questions, we encourage you to review our information with your doctor.
showDesktop,showTablet,showMobile
Donate today to support our lifesaving efforts.
Your gift enables us to support people with cancer and fund research breakthroughs.
Screening is the use of tests or exams to find a disease in people who don’t have symptoms. Lung carcinoid tumors are not common, and there are no widely recommended screening tests for these tumors in most people.
People with multiple endocrine neoplasia type 1 (MEN1) are at increased risk for these tumors, and some doctors recommend they have CT scans of the chest every 2-5 years.
Carcinoid tumors usually grow and spread slowly, so most are found at an early or localized stage, even if they have been causing symptoms for some time.
However, many people with peripheral carcinoid tumors or small central carcinoid tumors have no symptoms. Carcinoids that are not causing symptoms are often found when a chest x-ray or CT scan done for other reasons.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
So A, Pointon O, Hodgson R, Burgess J. An assessment of 18 F-FDG PET/CT for thoracic screening and risk stratification of pulmonary nodules in multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2018 May;88(5):683-691. doi: 10.1111/cen.13573.
Last Revised: August 28, 2018
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.